Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Recurrence 2Squamous Cell Carcinoma of Head and Neck 1Head and Neck Neoplasms 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Squamous Cell 1Brain Neoplasms 1

Interventions

Cyclophosphamide 67Dexamethasone 52Peripheral Blood Stem Cell Transplantation 37Lenalidomide 37Rituximab 35fludarabine phosphate 34Bortezomib 30Filgrastim 27Etoposide 27Cytarabine 25Carboplatin 25Busulfan 23Radiotherapy 22Melphalan 22Gemcitabine 22Cyclosporine 21pomalidomide 20fludarabine 20Whole-Body Irradiation 20Mycophenolic Acid 20Paclitaxel 19Methotrexate 18venetoclax 17Cisplatin 17pembrolizumab 16Calcium Dobesilate 16Bevacizumab 16Tacrolimus 14Antilymphocyte Serum 14Nivolumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Recurrence × Re-Irradiation × Clear all
NCT03126266 2024-12-05

Re-Irradiation of Progressive or Recurrent DIPG

University of Calgary

Phase NA Completed
27 enrolled

Recurrence

NCT01469247 2022-10-20

Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)

M.D. Anderson Cancer Center

Phase 1/2 Completed
12 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡